Transcend Therapeutics
transcendtherapeutics.comLocations
Waltham, MA, USA · New York, NY, USA · Canal Street, New York, NY, USA · Union Square, New York, NY, USA
industry
Biotechnology · Biotechnology Research · Health Care · Mental Health · Pharmaceutical · Therapeutics
Size
11 - 50 employees
Stage
Other
founded in
2021
Transcend Therapeutics is a clinical-stage biotechnology company focused on developing rapid-acting treatments for neuropsychiatric diseases. The company aims to address mental health conditions such as Post-Traumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD), particularly for patients who do not respond to existing therapies. The company’s lead program, TSND-201 (methylone), is being developed as a next-generation neuroplastogen designed to deliver fast and durable therapeutic effects. Its research emphasizes innovative psychoactive compounds that can improve outcomes while minimizing common limitations of traditional psychiatric medications. Backed by venture funding and an experienced leadership team with multiple FDA approvals, Transcend Therapeutics continues to advance clinical trials and expand its pipeline of mental health treatments.
Something looks off?Open jobs at Transcend Therapeutics
On-site & Remote
Job function
Seniority
Salary
© 2023 AlleyCorp. All rights reserved. | Privacy Policy | Terms of Service